Gainers
- eFFECTOR Therapeutics, Inc. EFTR rose 25.5% to $14.41 in pre-market trading after the company, in collaboration with investigators at Baylor College of Medicine, announced the presentation of new data for zotatifin in animal models of triple-negative breast cancer at the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
- Camber Energy, Inc.. CEI rose 19.7% to $2.13 in pre-market trading after jumping around 96% on Thursday.
- Immuron Limited IMRN rose 14.8% to $4.04 in pre-market trading. Immuron announced in a publication from the Hebrew University Hadassah Medical Center 'Augmented Antiviral T Cell Immunity by Oral Administration of Imm-124e in Preclinical Models and a Phase I/iia Clinical Trial: a Method for the Prevention and Treatment of Covid-19.'
- Sundial Growers Inc. SNDL rose 14.3% to $0.7407 in pre-market trading after the company announced plans to acquire Alcanna for total consideration of approximately $346 million.
- Momentive Global Inc. MNTV rose 10.9% to $23.98 in pre-market trading. Momentive Global is weighing options, including a potential sale after receiving takeover interest, Bloomberg reported.
- Vaxart, Inc. VXRT rose 9.7% to $7.78 in pre-market trading after the company reported a Duke University-led study published in bioRxiv showed that the company's investigational oral tablet vaccine reduced the airborne transmission of SARS-CoV-2 virus in an animal model.
- InflaRx N.V. IFRX rose 9.7% to $2.60 in pre-market trading.
- Eloxx Pharmaceuticals, Inc. ELOX shares rose 9.6% to $1.71 in pre-market trading.
- Soligenix, Inc. SNGX shares rose 7.1% to $1.06 in pre-market trading after gaining 5% on Thursday.
- DatChat, Inc. DATS shares rose 6.6% to $8.57 in pre-market trading after gaining over 9% on Thursday.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- Macquarie Infrastructure Corporation MIC shares fell 91.1% to $3.58 in pre-market trading.
- Allogene Therapeutics, Inc. ALLO shares fell 38.1% to $15.09 in pre-market trading after the company reported the FDA placed a hold on the company's AlloCAR T clinical trials.
- Cellectis S.A. CLLS fell 21.4% to $9.44 in pre-market trading.
- Agile Therapeutics, Inc. AGRX shares fell 19.8% to $0.7551 in pre-market trading after the company announced an offering of common stock and warrants.
- Cidara Therapeutics, Inc. CDTX fell 19.8% to $1.50 in pre-market trading after the company reported commencement of concurrent common and preferred stock offering.
- MaxCyte, Inc. MXCT fell 12.2% to $9.40 in pre-market trading.
- Rocket Lab USA, Inc. RKLB shares fell 8.2% to $14.20 in pre-market trading after gaining over 10% on Thursday.
- Huaneng Power International, Inc. HNP fell 6.2% to $19.53 in pre-market trading.
ALLOAllogene Therapeutics Inc
$2.048.30%
CDTXCidara Therapeutics Inc
$18.91-13.3%
CLLSCellectis SA
$1.581.28%
DATSDatChat Inc
$4.20-9.68%
EFTReFFECTOR Therapeutics Inc
$0.0783-56.5%
ELOXEloxx Pharmaceuticals Inc
$0.000001-100.0%
IFRXInflaRx NV
$2.34-1.27%
IMRNImmuron Ltd
$2.201.38%
MXCTMaxCyte Inc
$4.60-3.36%
RKLBRocket Lab USA Inc
$30.53-3.29%
SNDLSNDL Inc
$1.75-%
SNGXSoligenix Inc
$2.46-1.84%
VXRTVaxart Inc
$0.79002.64%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in